» Articles » PMID: 24880340

Identification of Erythroferrone As an Erythroid Regulator of Iron Metabolism

Overview
Journal Nat Genet
Specialty Genetics
Date 2014 Jun 2
PMID 24880340
Citations 469
Authors
Affiliations
Soon will be listed here.
Abstract

Recovery from blood loss requires a greatly enhanced supply of iron to support expanded erythropoiesis. After hemorrhage, suppression of the iron-regulatory hormone hepcidin allows increased iron absorption and mobilization from stores. We identified a new hormone, erythroferrone (ERFE), that mediates hepcidin suppression during stress erythropoiesis. ERFE is produced by erythroblasts in response to erythropoietin. ERFE-deficient mice fail to suppress hepcidin rapidly after hemorrhage and exhibit a delay in recovery from blood loss. ERFE expression is greatly increased in Hbb(th3/+) mice with thalassemia intermedia, where it contributes to the suppression of hepcidin and the systemic iron overload characteristic of this disease.

Citing Articles

Editorial: MDS: new scientific and clinical developments.

Blum S, Symeonidis A, Germing U Front Oncol. 2025; 15:1568681.

PMID: 40078185 PMC: 11896990. DOI: 10.3389/fonc.2025.1568681.


Effect of a high-fat diet and iron overload on erythropoiesis in mice.

Varghese J, Varghese J, Jacob M Biochem Biophys Rep. 2025; 41:101919.

PMID: 39980584 PMC: 11841077. DOI: 10.1016/j.bbrep.2025.101919.


Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside.

Dong Y, Zheng M, Ding W, Guan H, Xiao J, Li F Redox Biol. 2025; 81:103551.

PMID: 39965404 PMC: 11876910. DOI: 10.1016/j.redox.2025.103551.


Hereditary disorders of ineffective erythropoiesis.

King R, Khoriaty R Blood Cells Mol Dis. 2025; 111:102910.

PMID: 39938185 PMC: 11884990. DOI: 10.1016/j.bcmd.2025.102910.


Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Erythroferrone in Anemic Rats with Chronic Kidney Disease and Chemotherapy-Induced Anemia: An Early Biomarker for Hemoglobin Response and rHuEPO Hyporesponsiveness.

Zhang L, Xu P, Yan X ACS Pharmacol Transl Sci. 2025; 8(1):189-202.

PMID: 39816799 PMC: 11729431. DOI: 10.1021/acsptsci.4c00575.


References
1.
Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth M . Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009; 41(4):478-81. DOI: 10.1038/ng.320. View

2.
Peyssonnaux C, Zinkernagel A, Schuepbach R, Rankin E, Vaulont S, Haase V . Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest. 2007; 117(7):1926-32. PMC: 1884690. DOI: 10.1172/JCI31370. View

3.
Andriopoulos Jr B, Corradini E, Xia Y, Faasse S, Chen S, Grgurevic L . BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009; 41(4):482-7. PMC: 2810136. DOI: 10.1038/ng.335. View

4.
Huang F, Pinkus J, Pinkus G, Fleming M, Andrews N . A mouse model of juvenile hemochromatosis. J Clin Invest. 2005; 115(8):2187-91. PMC: 1180543. DOI: 10.1172/JCI25049. View

5.
Guo S, Casu C, Gardenghi S, Booten S, Aghajan M, Peralta R . Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice. J Clin Invest. 2013; 123(4):1531-41. PMC: 3613931. DOI: 10.1172/JCI66969. View